Jayendra Patel's research topics

Jayendra Patel

Concepts (71)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Antipsychotic Agents	4	2009	303	0.380	Why?
Metabolome	1	2009	39	0.290	Why?
Schizophrenia	3	2012	275	0.170	Why?
Mental Disorders	1	2009	825	0.170	Why?
Schizophrenic Psychology	2	2012	74	0.140	Why?
Psychotic Disorders	2	2012	150	0.130	Why?
Psychiatric Status Rating Scales	4	2013	382	0.120	Why?
Double-Blind Method	4	2012	745	0.110	Why?
Antidepressive Agents	2	2013	238	0.100	Why?
Memantine	1	2013	22	0.100	Why?
Remedial Teaching	1	2012	2	0.090	Why?
Computer-Assisted Instruction	1	2012	80	0.090	Why?
Cognition Disorders	1	2012	224	0.080	Why?
Metabolic Diseases	1	2009	59	0.070	Why?
Body Mass Index	2	2009	900	0.070	Why?
Body Weight	1	2009	377	0.070	Why?
Dose-Response Relationship, Drug	1	2009	858	0.060	Why?
Depression	1	2013	908	0.060	Why?
Sex Factors	1	2009	995	0.060	Why?
Follow-Up Studies	2	2009	2496	0.060	Why?
Haloperidol	1	2005	17	0.060	Why?
Event-Related Potentials, P300	1	2005	3	0.060	Why?
Clozapine	1	2005	32	0.050	Why?
Adult	7	2013	17511	0.050	Why?
Time Factors	2	2009	3777	0.050	Why?
Metabolic Syndrome	1	2005	146	0.050	Why?
Bipolar Disorder	1	2006	249	0.050	Why?
Adolescent	2	2009	6350	0.040	Why?
Male	7	2013	31292	0.040	Why?
Female	7	2013	34309	0.040	Why?
Drug Therapy, Combination	2	2013	463	0.040	Why?
Young Adult	1	2009	4855	0.040	Why?
Quality of Life	1	2005	1265	0.030	Why?
Treatment Outcome	3	2013	5820	0.030	Why?
Humans	7	2013	65645	0.030	Why?
Excitatory Amino Acid Agonists	1	2013	19	0.030	Why?
Drug Synergism	1	2013	142	0.020	Why?
Diagnostic and Statistical Manual of Mental Disorders	1	2013	118	0.020	Why?
Receptors, N-Methyl-D-Aspartate	1	2013	90	0.020	Why?
Drug Monitoring	1	2013	203	0.020	Why?
Inservice Training	1	2012	85	0.020	Why?
Evidence-Based Practice	1	2012	86	0.020	Why?
Neuropsychological Tests	1	2012	414	0.020	Why?
Feasibility Studies	1	2012	593	0.020	Why?
Pilot Projects	1	2012	1026	0.020	Why?
Anthropometry	1	2005	86	0.010	Why?
Cholesterol, HDL	1	2005	71	0.010	Why?
Fasting	1	2005	52	0.010	Why?
Chlorpromazine	1	2005	8	0.010	Why?
Psychotherapy	1	2006	102	0.010	Why?
Combined Modality Therapy	1	2006	372	0.010	Why?
Benzodiazepines	1	2005	107	0.010	Why?
Pain Measurement	1	2005	344	0.010	Why?
Anxiety Disorders	1	2006	201	0.010	Why?
Recurrence	1	2006	664	0.010	Why?
Triglycerides	1	2005	248	0.010	Why?
Depressive Disorder	1	2006	284	0.010	Why?
Cerebral Cortex	1	2005	270	0.010	Why?
Hypoglycemic Agents	1	2005	225	0.010	Why?
Pain	1	2005	400	0.010	Why?
Blood Pressure	1	2005	535	0.010	Why?
Blood Glucose	1	2005	502	0.010	Why?
Comorbidity	1	2006	1120	0.010	Why?
Longitudinal Studies	1	2006	1288	0.010	Why?
Insulin	1	2005	696	0.010	Why?
Middle Aged	2	2012	18439	0.010	Why?
Prognosis	1	2006	1791	0.010	Why?
Prevalence	1	2005	1453	0.010	Why?
Disease Progression	1	2005	1227	0.010	Why?
Prospective Studies	1	2006	3329	0.010	Why?
Risk Factors	1	2006	5466	0.010	Why?

Patel's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (71)

Explore

Co-Authors (2)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors